Search

everythinglearnresearchcommunity

for

Search:↓

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Mutations in certain receptors can cause diseases and offer new treatment options.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

New treatments for male hypogonadism are effective and should be personalized.

Finasteride may improve prostate cancer treatment outcomes.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Analog 23 is a promising compound for prostate cancer treatment.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Eclipta prostrata has many traditional uses and health benefits, but more research is needed to understand how it works and ensure it's safe.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

New compounds with carborane showed anti-androgen effects similar to flutamide.